Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
CASE-BASED REVIEW
Tjalma syndrome in late-onset systemic lupus erythematosus
1
Institute of Rheumatology, Belgrade, Serbia
2
Institute of Rheumatology, Belgrade, Medical Faculty, University of Belgrade, Serbia
Submission date: 2025-07-17
Final revision date: 2026-03-12
Acceptance date: 2026-04-24
Publication date: 2026-07-10
Reumatologia 2026;64(4):345-352
KEYWORDS
TOPICS
ABSTRACT
Tjalma syndrome, also named pseudo-pseudo Meigs syndrome, is a rare complication of serositis in patients with systemic lupus erythematosus (SLE). It is associated with a high level of the ovarian tumor marker CA-125 and pleural effusion and ascites, which can suggest an ovarian tumor (benign or malignant), in patients with SLE.
Available literature data include case reports of female patients with SLE ranging in age from 14 to 82. Patients under 50 years of age predominate. Our own experience led us to analyze the observations in this review against the background of our experience with a female patient with late- onset SLE. This review discusses why exploration of paraneoplastic syndrome can delay immunosuppressive therapy for this serious SLE manifestation. The main goal of this case-based review is to compare the clinical and laboratory findings of our patient with those reported in the literature and to raise awareness of this rare entity.
REFERENCES (31)
1.
Gimeno-Torres L, Carrión-Barberà I, Durán X, et al. Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a case-control study. Lupus 2021; 30: 2095–2101, DOI: 10.1177/09612033211049305.
2.
Liang Y, Leng RX, Pan HF, Ye DQ. The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatol Int 2017; 37: 305–311, DOI: 10.1007/s00296-016-3630-0.
3.
Zhao J, Bai W, Zhu P, et al.; CSTAR co-authors. Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus. Lupus 2016; 25: 652–657, DOI: 10.1177/0961203315625460.
4.
Li PH, Wong WH, Lee TL, et al. Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford) 2013; 52: 337–345, DOI: 10.1093/rheumatology/kes261.
5.
Lazaro D. Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging 2007; 24: 701–715, DOI: 10.2165/00002512-200724090-00001.
6.
Boddaert J, Huong DLT, Amoura Z, et al. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 2004; 83: 348–359, DOI: 10.1097/01.md.0000147737.57861.7c.
7.
Bindroo MA, Majid N, Ekbote G, et al. Late Onset Systemic Lupus Erythematosus – Clinical and Autoantibody Profile and its Comparison with Young Onset Systemic Lupus Erythematosus. Mediterr J Rheumatol 2023; 34: 454–459, DOI: 10.31138/ mjr.290723.los.
8.
Li PH, Wong WH, Lee TL, et al. Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford) 2013; 52: 337–345, DOI: 10.1093/rheumatology/kes261.
9.
Zhong Y, Ma J, Zhang L, et al. Association of serum tumor markers with serous effusion in systemic lupus erythematosus. Heliyon 2023; 9: e23213, DOI: 10.1016/j.heliyon.2023.e23213.
10.
Tjalma WA. Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome. Gynecol Oncol 2005; 97: 288–291, DOI: 10.1016/j.ygyno.2004.12.022.
11.
Zhao YR, Zhao Z, Zhang J, et al. Efficacy of rituximab therapy for 10 patients suffering from systemic lupus erythematosus with intestinal involvement. Zhonghua Nei Ke Za Zhi 2024; 63: 198–202, DOI: 10.3760/cma.j.cn112138-20231016-00220.
12.
Ren M, He Y, Zhang J, et al. Generalised Blisters and Respiratory distress: A Case of Bullous Systemic Lupus Erythematosus. Clin Cosmet Investig Dermatol 2024; 17: 1975–1979, DOI: 10.2147/CCID.S484441.
13.
Deniz R, Hacımurtazaoğlu-Demir G, Karaalioğlu B, et al. Lupus nephritis presenting with massive ascites and pleural effusion (pseudo-pseudo Meigs’ syndrome). J Rheum Dis 2024; 31: 116–119, DOI: 10.4078/jrd.2023.0052.
14.
Li Q, Tian B. Case report: Three cases of systemic lupus erythematosus presenting primarily with massive ascites and significantly elevated CA-125 levels and a review of pseudo-pseudo Meigs’ syndrome in literature. Front Immunol 2024; 15: 1423631, DOI: 10.3389/fimmu.2024.1423631.
15.
Tan Q, Xu LF, Yan T, et al. Deciphering the puzzle: a case report of Tjalma syndrome (pseudo-pseudo Meigs’ syndrome) with profoundly elevated CA-125 and pleural effusion. Front Immunol 2023; 14: 1277683, DOI: 10.3389/fimmu.2023.1277683.
16.
Dang V, Rofail A, Bowman JM, Peloquin J. A Case of Pseudo- Pseudo Meigs’ Syndrome Despite Optimized Immunosuppressive Therapy for Systemic Lupus Erythematosus. Cureus 2023; 15: e46753, DOI: 10.7759/cureus.46753.
17.
Chao YH, Chen HY. Rare cause of ascites and pleural effusion: The first case report and literature review of pseudo-pseudo Meig’s syndrome in Taiwan. J Formos Med Assoc 2022; 121: 2633–2638, DOI: 10.1016/j.jfma.2022.03.020.
18.
Wang JD, Yang YF, Zhang XF, Huang J. Systemic lupus erythematosus presenting with progressive massive ascites and CA-125 elevation indicating Tjalma syndrome? A case report. World J Clin Cases 2022; 10: 9447–9453, DOI: 10.12998/wjcc.v10.i26.9447.
19.
Al Hammadi N. New-onset systemic lupus erythematosus presenting with pseudo-pseudo Meigs’ syndrome. J Family Med Prim Care 2022; 11: 5673–5675, DOI: 10.4103/jfmpc.jfmpc_101_22.
20.
Martins A, Pimenta S, Rato M, Oliveira D, Martins FR, Pinhei- ro FO, Fonseca D, Costa L. Pseudo-pseudo Meigs syndrome: an uncommon onset of Systemic Lupus Erythematosus. ARP Rheumatol 2022; 3: 315–318.
21.
Horino T, Ogasawara M, Kashio T, et al. Lupus-related protein- losing enteropathy associated with pseudo-pseudo Meigs’ syndrome and successfully treated with hydroxychloroquine. Rom J Intern Med 2022; 60: 85–89, DOI: 10.2478/rjim-2021-0032.
22.
Meena DS, Kumar B, Gopalakrishnan M, et al. Pseudo-pseudo Meigs’ syndrome (PPMS) in chronic lupus peritonitis: a case report with review of literature. Mod Rheumatol Case Rep 2021; 5: 300–305, DOI: 10.1080/24725625.2021.1916160.
23.
Gao F, Xu Y, Yang G. Pseudo-pseudo Meigs’ syndrome presenting with a combination of polyserositis, elevated serum CA 125 in systemic lupus erythematosus: a case report. Medicine (Baltimore) 2019; 98: e15393, DOI: 10.1097/MD. 0000000000015393.
24.
Li T, Xie QB. A case report of pseudo-pseudo Meigs’ syndrome. Chin Med J (Engl) 2019; 132: 1497–1498, DOI: 10.1097/CM9.0000000000000231.
25.
Ahmed O, Malley T, Kitchen J. A case of pseudo-pseudo Meigs’ syndrome. Oxf Med Case Rep 2019; 2019: omy136, DOI: 10.1093/omcr/omy136. Erratum in: Oxf Med Case Rep 2019; 2019: omz018, DOI: 10.1093/omcr/omz018.
26.
Tansir G, Kumar P, Pius A, et al. Pseudo-pseudo Meigs’ syndrome: a rare presentation of systemic lupus erythematosus. Reumatismo 2019; 71 (2): 108–112, DOI: 10.4081/reumatismo. 2019.1140.
27.
Torres Jiménez AR, Solís-Vallejo E, Céspedes-Cruz A, et al. Tjalma syndrome (pseudo-pseudo Meigs’) as initial manifestation of juvenile-onset systemic lupus erythematosus. Reumatol Clin (Engl Ed) 2019; 15: e41–e43, DOI: 10.1016/j.reuma. 2017.04.003.
28.
Cheah CK, Ramanujam S, Mohd Noor N, et al. A case of mixed connective tissue disease with pseudo-pseudo Meigs’ syndrome (PPMS)-like features. Lupus 2016; 25: 214–216, DOI: 10.1177/0961203315606441.
29.
McVorran S, Song J, Pochineni V, Abrudescu-Opran A. Systemic Lupus Erythematosus Presenting with Massive Ascites: A Case of Pseudo-Pseudo Meigs Syndrome. Case Rep Rheumatol 2016; 2016: 8701763, DOI: 10.1155/2016/8701763.
30.
Seo MR, Sung JY, Cho HJ, et al. Ascites associated with uterine leiomyoma in a 22-year-old woman with systemic lupus erythematosus. Lupus 2014; 23: 1207–1210, DOI: 10.1177/ 0961203314540763.
31.
Ural UM, Kiliç A, Güngör T, et al. Tjalma’s or pseudo-pseudo- Meigs’ syndrome: a case report. Clin Exp Dermatol 2008; 33: 363–364, DOI: 10.1111/j.1365-2230.2007.02665.x.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
